Evaluating Safety Reporting in Paediatric Antibiotic Trials, 2000 –2016: A Systematic Review and Meta-Analysis

Conclusions and RelevanceOverall, AEs in paediatric antibiotic CTs were predictable and class-specific, and no unexpected (age-specific) side effects were identified. Smaller, open-label, dose-finding, high-quality, single-arm pharmacokinetic trials seem potentially sufficient for certain common antibiotic classes, extrapolating well-established safety profiles determined from large adult efficacy trials. This approach could reduce duration and enhance subsequent registration of urgently needed new antibiotics. This will need to be combined with enhanced methods of pharmacovigilance for monitoring of emerging AEs in routine clinical practice. (Source: Drugs)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2j3GLJJ
via IFTTT